Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibrolamellar Cancer”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Testing effectiveness (Phase 2)Study completedNCT02234986
What this trial is testing

A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma

Who this might be right for
Advanced Adult Hepatocellular CarcinomaAdvanced Fibrolamellar Carcinoma
CASI pharmaceuticals, Inc. 35
Testing effectiveness (Phase 2)Looking for participantsNCT06027086
What this trial is testing

DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

Who this might be right for
Fibrolamellar Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Early research (Phase 1)Looking for participantsNCT05937295
What this trial is testing

FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint Inhibition

Who this might be right for
Fibrolamellar Hepatocellular Carcinoma
University Hospital Tuebingen 20
Not applicableStudy completedNCT04874519
What this trial is testing

Registry to Collect Health Information Related to Fibrolamellar Cancer

Who this might be right for
Fibrolamellar CancerFLCLiver Cancer
Memorial Sloan Kettering Cancer Center 12
Early research (Phase 1)Not Yet RecruitingNCT07430202
What this trial is testing

A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

Who this might be right for
Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Testing effectiveness (Phase 2)Ended earlyNCT01215565
What this trial is testing

Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma

Who this might be right for
Hepatocellular CarcinomaFibrolamellar Hepatocellular Carcinoma
Assistance Publique - Hôpitaux de Paris 4
Early research (Phase 1)Active Not RecruitingNCT03860272
What this trial is testing

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

Who this might be right for
Advanced CancerAngiosarcomaColorectal Cancer Without Liver Metastases+5 more
Agenus Inc. 499
Not applicableUnknownNCT05681949
What this trial is testing

Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards

Who this might be right for
Hepatocellular CarcinomaFibrolamellar Hepatocellular CarcinomaCholangiocarcinoma, Perihilar+3 more
Charite University, Berlin, Germany 1,200
Testing effectiveness (Phase 2)WithdrawnNCT04025567
What this trial is testing

Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral

Who this might be right for
Metastatic Hepatocellular CarcinomaHepatocellular Carcinoma
National Cancer Institute (NCI)
Not applicableWithdrawnNCT03748927
What this trial is testing

Natural History Study of Children and Adults With Fibrolamellar Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatocellular Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06620302
What this trial is testing

Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma

Who this might be right for
Childhood Fibrolamellar CarcinomaRecurrent Childhood Fibrolamellar CarcinomaRecurrent Childhood Malignant Solid Neoplasm+6 more
Children's Oncology Group 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT06521567
What this trial is testing

Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

Who this might be right for
MelanomaHodgkin LymphomaHigh and Low Grade Glioma+9 more
GlaxoSmithKline 83
Not applicableUnknownNCT05730686
What this trial is testing

FibroLamellar Carcinoma: an International Registry Study

Who this might be right for
Fibrolamellar Cancer of the Liver
Imperial College London 200
Early research (Phase 1)Study completedNCT02159989
What this trial is testing

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more
National Cancer Institute (NCI) 83
Testing effectiveness (Phase 2)Looking for participantsNCT05468359
What this trial is testing

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

Who this might be right for
Refractory Solid TumorHepatocellular CarcinomaMalignant Solid Tumor+3 more
St. Jude Children's Research Hospital 64
Testing effectiveness (Phase 2)Looking for participantsNCT04380545
What this trial is testing

Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer

Who this might be right for
Stage III Hepatocellular Carcinoma AJCC v8Stage IIIA Hepatocellular Carcinoma AJCC v8Stage IIIB Hepatocellular Carcinoma AJCC v8+4 more
M.D. Anderson Cancer Center 15
Early research (Phase 1)Looking for participantsNCT06789198
What this trial is testing

Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA

Who this might be right for
Fibrolamellar Hepatocellular Carcinoma (FLC)
University Hospital Tuebingen 20
Early research (Phase 1)Looking for participantsNCT04248569
What this trial is testing

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

Who this might be right for
Fibrolamellar Hepatocellular Carcinoma (FLC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 56
Testing effectiveness (Phase 2)Study completedNCT01642186
What this trial is testing

Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)

Who this might be right for
Fibrolamellar CarcinomaFibrolamellar Liver Cancer
Memorial Sloan Kettering Cancer Center 28
Large-scale testing (Phase 3)Active Not RecruitingNCT03533582
What this trial is testing

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Who this might be right for
Childhood Hepatocellular CarcinomaChildhood Malignant Liver NeoplasmFibrolamellar Carcinoma+2 more
Children's Oncology Group 537
Load More Results